Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
ICN 2023
Programm
Personen
Suche
DE
Poster zum Thema "Glial, glioneuronal and embryonal tumors II"
Zurück
PS6-NO-A57
A novel definition of low-grade astrocytoma IDH-mutant to inform observational follow-up and the upcoming era of IDH mutant inhibitors
Franck Bielle (Paris, FR)
PS6-NO-A58
Beyond IDH1 R132H mutation – clinicopathological characteristics of non-canonical IDH mutant gliomas
Elena Martinez-Saez (Barcelona, ES)
PS6-NO-A59
Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma
Jason Huse (Houston, TX, US)
PS6-NO-A60
Comprehensive genomic profiling of ATRX-deficient IDH-wildtype adult high-grade gliomas reveals clinically relevant genetic patterns
Bálint Scheich (Budapest, HU)
PS6-NO-A61
Gliomas with immunohistochemical loss of MMR proteins – clinico-pathological evaluation, a tertiary care cancer institute experience
Sridhar Epari (Mumbai, IN)
PS6-NO-A62
Proteome signatures are closely associated with histomorphology in Embryonal Tumors with Multilayered Rosettes (ETMR)
Matthias Dottermusch (Hamburg, DE)
PS6-NO-A63
Adult medulloblastoma – clinico-molecular spectrum, an institutional experience
Vishesha Adhvaryu (Mumbai, IN)
PS6-NO-A64
DNA methylation profiling of adult spinal glial tumours – results from a large single centre study
Matthew Clarke (London, GB)
v1.21.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz